Dogwood Therapeutics Inc., a biotechnology company operating within the health care sector, is headquartered in Alpharetta, United States. The company is listed on the Nasdaq exchange and trades under the currency of USD. As of November 2, 2026, Dogwood Therapeutics Inc. reported a close price of $1.04. The company’s market capitalization stands at approximately $39,374,748 USD.
Dogwood Therapeutics Inc. has experienced significant fluctuations in its stock price over the past year. The 52-week high was recorded at $7.044 on December 11, 2025, while the 52-week low was noted at $0.901 on November 2, 2026. This volatility reflects the dynamic nature of the biotechnology sector and the challenges faced by companies in this field.
The company’s financial metrics indicate a Price Earnings (P/E) ratio of -0.58, suggesting that it is currently not generating profits. This is not uncommon for biotechnology firms, which often invest heavily in research and development before achieving profitability.
Dogwood Therapeutics Inc. is dedicated to developing novel antiviral therapies aimed at treating diseases associated with viral-triggered abnormal immune responses. The company’s mission is to serve patients in the United States by providing innovative therapeutic solutions. For more detailed information about their activities and offerings, interested parties can visit their website at www.virios.com , accessible through Nasdaq.
The company’s focus on antiviral therapies positions it within a critical area of healthcare, especially given the ongoing global challenges related to viral diseases. Dogwood Therapeutics Inc. continues to invest in research and development to advance its therapeutic pipeline, with the goal of addressing unmet medical needs in the treatment of viral infections.
In summary, Dogwood Therapeutics Inc. is a biotechnology company with a clear focus on developing antiviral therapies. Despite current financial challenges, as indicated by its negative P/E ratio, the company remains committed to its mission of serving patients in the United States through innovative healthcare solutions.
